Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Humanitarian Device Exemption Compassionate Use Protocol of TheraSphere for Treatment of Unresectable Metastatic Cancer to the Liver

NCT00532740 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00532740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00532740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Humanitarian Device Exemption Compassionate Use Protocol of TheraSphere for Treatment of Unresectable Metastatic Cancer to the Liver
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
December 31, 2004
Completion date
March 16, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, metastatic cancer